Aberrant microRNA expression in B lymphocytes from patients with primary warm autoimmune haemolytic anaemia

References

• Michalak SS, Olewicz-Gawlik A, Rupa-Matysek J, et al. Autoimmune hemolytic anemia: current knowledge and perspectives. Immun Ageing. 2020;17(1):38.
   PubMed Web of Science ®Google Scholar
• Jäger U, Barcellini W, Broome CM, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the First International Consensus Meeting. Blood Rev. 2020;41:100648.
   PubMed Web of Science ®Google Scholar
• Fagiolo E, Toriani-Terenzi C. Mechanisms of immunological tolerance loss versus erythrocyte self-antigens and autoimmune hemolytic anemia. Autoimmunity. 2003;36(4):199–204.
   PubMed Web of Science ®Google Scholar
• Zhao M, Duan N, Wang Y, et al. CD5+ B lymphocytes secrete IL-10 rather than TGF-β1 which control the immune response in autoimmune haemolytic anaemia/Evans syndrome. Autoimmunity. 2019;52(1):12–20.
   PubMed Web of Science ®Google Scholar
• Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, et al. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234(5):5451–5465.
   PubMed Web of Science ®Google Scholar
• Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9(2):102–114.
   PubMed Web of Science ®Google Scholar
• Mehta A, Baltimore D. MicroRNAs as regulatory elements in immune system logic. Nat Rev Immunol. 2016;16(5):279–294.
   PubMed Web of Science ®Google Scholar
• Kumar Kingsley SM, Vishnu Bhat B. Role of MicroRNAs in the development and function of innate immune cells. Int Rev Immunol. 2017;36(3):154–175.
   PubMed Web of Science ®Google Scholar
• Jeker LT, Bluestone JA. MicroRNA regulation of T-cell differentiation and function. Immunol Rev. 2013;253(1):65–81.
   PubMedGoogle Scholar
• Zhou B, Wang S, Mayr C, et al. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci U S A. 2007;104(17):7080–7085.
   PubMed Web of Science ®Google Scholar
• Pauley KM, Cha S, Chan EK. MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun. 2009;32(3–4):189–194.
   PubMed Web of Science ®Google Scholar
• Long H, Wang X, Chen Y, et al. Dysregulation of microRNAs in autoimmune diseases: pathogenesis, biomarkers and potential therapeutic targets. Cancer Lett. 2018;428:90–103.
   PubMed Web of Science ®Google Scholar
• Soltanzadeh-Yamchi M, Shahbazi M, Aslani S, et al. MicroRNA signature of regulatory T cells in health and autoimmunity. Biomed Pharmacother. 2018;100:316–323.
   PubMed Web of Science ®Google Scholar
• Wang-Renault SF, Boudaoud S, Nocturne G, et al. Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome. Ann Rheum Dis. 2018;77(1):133–140.
   PubMed Web of Science ®Google Scholar
• Xing L, Xu W, Qu Y, et al. miR-150 regulates B lymphocyte in autoimmune hemolytic anemia/Evans syndrome by c-Myb. Int J Hematol. 2018;107(6):666–672.
   PubMed Web of Science ®Google Scholar
• Leukemia and Lymphoma Group, Chinese Society of Hematology, Chinese Medical Association. Chinese expert consensus on the diagnosis and treatment of autoimmune hemolytic anemia (2017) Red Blood Cell Disease (Anemia). Chin J Hematol. 2017;38(4):265–267 [Chinese].
   Google Scholar
• 't Hoen PA, Ariyurek Y, Thygesen HH, et al. Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms. Nucleic Acids Res. 2008;36(21):e141.
   PubMed Web of Science ®Google Scholar
• Audic S, Claverie JM. The significance of digital gene expression profiles. Genome Res. 1997;7(10):986–995.
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Statist. 2001;29:1165–1188.
   Web of Science ®Google Scholar
• Sokol RJ, Hewitt S, Stamps BK. Autoimmune haemolysis: an 18-year study of 865 cases referred to a regional transfusion centre. Br Med J (Clin Res Ed). 1981;282(6281):2023–2027.
   PubMed Web of Science ®Google Scholar
• Lupescu A, Bissinger R, Goebel T, et al. Enhanced suicidal erythrocyte death contributing to anemia in the elderly. Cell Physiol Biochem. 2015;36(2):773–783.
   PubMedGoogle Scholar
• Barcellini W, Giannotta J, Fattizzo B. Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures. Expert Rev Hematol. 2020;13(6):585–597.
   PubMed Web of Science ®Google Scholar
• Thai TH, Calado DP, Casola S, et al. Regulation of the germinal center response by microRNA-155. Science. 2007;316(5824):604–608.
   PubMed Web of Science ®Google Scholar
• Vigorito E, Perks KL, Abreu-Goodger C, et al. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity. 2007;27(6):847–859.
   PubMed Web of Science ®Google Scholar
• Chen CZ, Li L, Lodish HF, et al. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303(5654):83–86.
   PubMed Web of Science ®Google Scholar
• Xiao C, Calado DP, Galler G, et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell. 2007;131(1):146–159.
   PubMed Web of Science ®Google Scholar
• Wu H, Deng Y, Feng Y, et al. Epigenetic regulation in B-cell maturation and its dysregulation in autoimmunity. Cell Mol Immunol. 2018;15(7):676–684.
   PubMed Web of Science ®Google Scholar
• Liu Y, Dong J, Mu R, et al. MicroRNA-30a promotes B cell hyperactivity in patients with systemic lupus erythematosus by direct interaction with Lyn. Arthritis Rheum. 2013;65(6):1603–1611.
   PubMedGoogle Scholar
• Luo S, Liu Y, Liang G, et al. The role of microRNA-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus. Clin Epigenet. 2015;7(1):24.
   PubMedGoogle Scholar
• Xiao C, Srinivasan L, Calado DP, et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol. 2008;9(4):405–414.
   PubMed Web of Science ®Google Scholar
• van Nieuwenhuijze A, Dooley J, Humblet-Baron S, et al. Defective germinal center B-cell response and reduced arthritic pathology in microRNA-29a-deficient mice. Cell Mol Life Sci. 2017;74(11):2095–2106.
   PubMed Web of Science ®Google Scholar
• Dai Y, Huang YS, Tang M, et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus. 2007;16(12):939–946.
   PubMed Web of Science ®Google Scholar
• Stanczyk J, Pedrioli DM, Brentano F, et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 2008;58(4):1001–1009.
   PubMed Web of Science ®Google Scholar
• Guo Y, Qu W, Wang Y, et al. The role of miR-155 in pathogenesis of immune thrombocytopenia. Chin J Hematol. 2016;96(14):1103–1107 [Chinese].
   Google Scholar
• Junker A, Krumbholz M, Eisele S, et al. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain. 2009;132(12):3342–3352.
   PubMedGoogle Scholar
• Talebi F, Ghorbani S, Chan WF, et al. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis. J Neuroinflammation. 2017;14(1):55.
   PubMedGoogle Scholar
• Liu X, Luo M, Meng H, et al. MiR-181a regulates CD4+ T cell activation and differentiation by targeting IL-2 in the pathogenesis of myasthenia gravis (Published online ahead of print, 2019 Jul 26). Eur J Immunol. 2019.
   Google Scholar
• Li H, Ning Y, Li S, et al. Expression and clinical significance of miR-181a and miR-203 in systemic lupus erythematosus patients. Eur Rev Med Pharmacol Sci. 2017;21(21):4790–4796.
   PubMed Web of Science ®Google Scholar
• Zhuang Q, Shen J, Chen Z, et al. MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4. CBM. 2018;23(4):515–525.
   Google Scholar
• Zhang Z, Zhang L, Wang B, et al. MiR-337-3p suppresses proliferation of epithelial ovarian cancer by targeting PIK3CA and PIK3CB. Cancer Lett. 2020;469:54–67.
   PubMed Web of Science ®Google Scholar
• Wang Z, Yao L, Li Y, et al. miR‑337‑3p inhibits gastric tumor metastasis by targeting ARHGAP10. Mol Med Rep. 2020;21(2):705–719.
   PubMed Web of Science ®Google Scholar
• Liu Q, Li J, Ma Y, et al. Clinical curative effect observation of rapamycin for 28 patients with resistant autoimmune hemolytic anemia. Chin J Hematol. 2012;33(3):2 [Chinese].
   Google Scholar
• Miano M, Calvillo M, Palmisani E, et al. Sirolimus for the treatment of multi-resistant autoimmune haemolytic anaemia in children. Br J Haematol. 2014;167(4):571–574.
   PubMed Web of Science ®Google Scholar
• Hauswirth AW, Skrabs C, Schützinger C, et al. Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas. Leuk Lymphoma. 2007;48(6):1139–1149.
   PubMed Web of Science ®Google Scholar